Paling Nicholas R D, Welham Melanie J
Department of Pharmacy & Pharmacology, University of Bath, Bath BA2 7AY, UK.
Biochem J. 2002 Dec 15;368(Pt 3):885-94. doi: 10.1042/BJ20021054.
The tyrosine phosphatase SHP-1 (Src homology phosphatase-1) has been widely implicated as a negative regulator of signalling in immune cells. We have investigated in detail the role of SHP-1 in interleukin-3 (IL-3) signal transduction by inducibly expressing wild-type (WT), C453S (substrate-trapping) and R459M (catalytically inactive) forms of SHP-1 in the IL-3-dependent cell line BaF/3. Expression of WT SHP-1 had little impact on IL-3-induced proliferation, but enhanced apoptosis following IL-3 withdrawal. Expression of R459M SHP-1 increased the proliferative response of BaF/3 cells to IL-3 and increased cell survival at low doses of IL-3 and following IL-3 withdrawal. Investigation into the biochemical consequences resulting from expression of these SHP-1 variants demonstrated that the beta chain of the IL-3 receptor (Aic2A) was hypo-phosphorylated in cells expressing WT SHP-1 and hyper-phosphorylated in those expressing R459M SHP-1. Further, ectopic expression of the trapping mutant, C453S SHP-1, protected Aic2A from dephosphorylation, suggesting that Aic2A is a SHP-1 substrate in BaF/3 cells. Examination of overall levels of tyrosine phosphorylation demonstrated that they were not perturbed in these transfectants. Activation-specific phosphorylation of STAT (signal transducer and activator of transcription) 5a/b, protein kinase B and ERK (extracellular-signal-regulated kinase)-1 and -2 was also unaffected by expression of WT or R459M SHP-1. However, overall levels of IL-3-induced tyrosine phosphorylation of STAT5 were reduced upon expression of WT SHP-1 and increased when R459M SHP-1 was expressed, consistent with STAT5 being a potential SHP-1 substrate. These results demonstrate that SHP-1 acts to negatively regulate IL-3-driven survival and proliferation, potentially via regulation of tyrosine phosphorylation of Aic2A and STAT5.
酪氨酸磷酸酶SHP-1(Src同源磷酸酶-1)被广泛认为是免疫细胞信号传导的负调节因子。我们通过在依赖白细胞介素-3(IL-3)的细胞系BaF/3中诱导表达野生型(WT)、C453S(底物捕获)和R459M(催化失活)形式的SHP-1,详细研究了SHP-1在IL-3信号转导中的作用。野生型SHP-1的表达对IL-3诱导的增殖影响不大,但在撤除IL-3后增强了细胞凋亡。R459M SHP-1的表达增加了BaF/3细胞对IL-3的增殖反应,并在低剂量IL-3时以及撤除IL-3后提高了细胞存活率。对这些SHP-1变体表达所产生的生化后果进行的研究表明,在表达野生型SHP-1的细胞中,IL-3受体的β链(Aic2A)磷酸化不足,而在表达R459M SHP-1的细胞中则过度磷酸化。此外,捕获突变体C453S SHP-1的异位表达保护Aic2A不被去磷酸化,这表明Aic2A是BaF/3细胞中的SHP-1底物。对酪氨酸磷酸化总体水平的检测表明,这些转染细胞中的酪氨酸磷酸化水平未受干扰。信号转导和转录激活因子(STAT)5a/b、蛋白激酶B以及细胞外信号调节激酶(ERK)-1和-2的激活特异性磷酸化也不受野生型或R459M SHP-1表达的影响。然而,野生型SHP-1表达后,IL-3诱导的STAT5酪氨酸磷酸化总体水平降低,而R459M SHP-1表达时则升高,这与STAT5是潜在的SHP-1底物一致。这些结果表明,SHP-1可能通过调节Aic2A和STAT5的酪氨酸磷酸化来负调节IL-3驱动的细胞存活和增殖。